EP1794318A4 - Criblage de medicaments et test de diagnostic moleculaire pour un depistage precoce du cancer colorectal, reactifs, procedes et trousses associes - Google Patents

Criblage de medicaments et test de diagnostic moleculaire pour un depistage precoce du cancer colorectal, reactifs, procedes et trousses associes

Info

Publication number
EP1794318A4
EP1794318A4 EP05801813A EP05801813A EP1794318A4 EP 1794318 A4 EP1794318 A4 EP 1794318A4 EP 05801813 A EP05801813 A EP 05801813A EP 05801813 A EP05801813 A EP 05801813A EP 1794318 A4 EP1794318 A4 EP 1794318A4
Authority
EP
European Patent Office
Prior art keywords
kits
reagents
methods
colorectal cancer
diagnostic test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05801813A
Other languages
German (de)
English (en)
Other versions
EP1794318A2 (fr
Inventor
Nancy M Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IntelliGeneScan Inc
Original Assignee
IntelliGeneScan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IntelliGeneScan Inc filed Critical IntelliGeneScan Inc
Publication of EP1794318A2 publication Critical patent/EP1794318A2/fr
Publication of EP1794318A4 publication Critical patent/EP1794318A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Data Mining & Analysis (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Databases & Information Systems (AREA)
EP05801813A 2004-09-30 2005-09-30 Criblage de medicaments et test de diagnostic moleculaire pour un depistage precoce du cancer colorectal, reactifs, procedes et trousses associes Withdrawn EP1794318A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61474604P 2004-09-30 2004-09-30
US65134405P 2005-02-08 2005-02-08
US11/242,111 US20060088862A1 (en) 2004-09-30 2005-09-29 Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods, and kits thereof
PCT/US2005/035027 WO2006039405A2 (fr) 2004-09-30 2005-09-30 Criblage de medicaments et test de diagnostic moleculaire pour un depistage precoce du cancer colorectal, reactifs, procedes et trousses associes

Publications (2)

Publication Number Publication Date
EP1794318A2 EP1794318A2 (fr) 2007-06-13
EP1794318A4 true EP1794318A4 (fr) 2009-09-02

Family

ID=36143056

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05801813A Withdrawn EP1794318A4 (fr) 2004-09-30 2005-09-30 Criblage de medicaments et test de diagnostic moleculaire pour un depistage precoce du cancer colorectal, reactifs, procedes et trousses associes

Country Status (7)

Country Link
US (2) US20060088862A1 (fr)
EP (1) EP1794318A4 (fr)
JP (2) JP2008514234A (fr)
KR (1) KR20070058577A (fr)
AU (2) AU2005292025A1 (fr)
CA (1) CA2580528A1 (fr)
WO (1) WO2006039405A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050014165A1 (en) * 2003-07-18 2005-01-20 California Pacific Medical Center Biomarker panel for colorectal cancer
US7962215B2 (en) 2004-07-23 2011-06-14 Synapse Biomedical, Inc. Ventilatory assist system and methods to improve respiratory function
US9050005B2 (en) 2005-08-25 2015-06-09 Synapse Biomedical, Inc. Method and apparatus for transgastric neurostimulation
US20080097153A1 (en) * 2006-08-24 2008-04-24 Ignagni Anthony R Method and apparatus for grasping an abdominal wall
US9079016B2 (en) * 2007-02-05 2015-07-14 Synapse Biomedical, Inc. Removable intramuscular electrode
JP2008263837A (ja) * 2007-04-19 2008-11-06 Univ Nagoya 肺腺癌細胞に対する薬剤の有効性評価法
WO2008144578A1 (fr) * 2007-05-17 2008-11-27 Synapse Biomedical, Inc. Dispositifs et procédés pour évaluer l'électromyogramme d'un point moteur en tant que biomarqueur
WO2008150962A2 (fr) * 2007-05-31 2008-12-11 California Pacific Medical Center Procédé pour prédire ou diagnostiquer un trouble ou une maladie gastro-intestinale
US8697350B2 (en) 2007-06-04 2014-04-15 Diagnoplex Biomarker combinations for colorectal cancer
US8883440B2 (en) 2007-07-26 2014-11-11 Nancy M. Lee Method to predict or diagnose a gastrointestinal disorder or disease
US8478412B2 (en) * 2007-10-30 2013-07-02 Synapse Biomedical, Inc. Method of improving sleep disordered breathing
US8428726B2 (en) 2007-10-30 2013-04-23 Synapse Biomedical, Inc. Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system
KR101051435B1 (ko) * 2008-10-22 2011-07-22 한국생명공학연구원 대장암 관련 마커를 이용한 대장암 진단 키트 및 이를 이용한 대장암 진단 방법
EP2398918B1 (fr) * 2009-02-20 2018-06-20 Onconome, Inc. Méthodes de diagnostic et de pronostic de cancer colorectal
KR101144324B1 (ko) 2009-12-30 2012-05-11 한국과학기술연구원 대장암 예후진단용 단백질 마커 디펜신?５와 ｒｏｄ１단백질의 조합 및 이들 각각에 대한 항체를 포함하는 대장암 예후진단키트
CA2824877A1 (fr) * 2011-01-28 2012-08-02 Biodesix, Inc. Test predictif de selection de patients atteints de cancers metastatiques du sein afin de recevoir une therapie hormonale et une polytherapie
GB201107466D0 (en) * 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
CN104297442B (zh) * 2014-11-03 2016-08-17 天津中医药大学 内源性小分子物质在快速检测早期心脏毒性方面的应用
US20210270834A1 (en) * 2018-06-08 2021-09-02 Kyungpook National University Industry-Academic Cooperation Foundation Composition for diagnosing diseases associated with cox2 overexpression and screening method therefor
US11471683B2 (en) 2019-01-29 2022-10-18 Synapse Biomedical, Inc. Systems and methods for treating sleep apnea using neuromodulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2843326B2 (ja) * 1987-12-10 1999-01-06 古河電気工業株式会社 コネクター用Ａ▲ｌ▼合金
CA2176496C (fr) * 1993-11-29 1999-09-28 Kathleen A. Clark Procede d'extraction d'acides nucleiques d'une grande variete d'organismes
JP4222835B2 (ja) * 2001-03-14 2009-02-12 株式会社Ｄｎａチップ研究所 癌の予測方法
WO2003040317A2 (fr) * 2001-11-02 2003-05-15 Pfizer Products Inc. Moyens therapeutiques et diagnostiques applicables au cancer du poumon
US20040018525A1 (en) * 2002-05-21 2004-01-29 Bayer Aktiengesellschaft Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasma
WO2004041076A2 (fr) * 2002-11-04 2004-05-21 Protein Design Labs, Inc. Methodes de detection du cancer colorectal
US20050014165A1 (en) * 2003-07-18 2005-01-20 California Pacific Medical Center Biomarker panel for colorectal cancer

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
CUENCA R E ET AL: "Characterization of GRO alpha, beta and gamma expression in human colonic tumours: potential significance of cytokine involvement", SURGICAL ONCOLOGY, BLACKWELL SCIENTIFIC PUBL., OXFORD, GB, vol. 1, no. 4, 1 August 1992 (1992-08-01), pages 323 - 329, XP023266891, ISSN: 0960-7404, [retrieved on 19920801] *
DATABASE Geneseq [online] 15 July 2004 (2004-07-15), "Protein #83 with increased gene expression in renal cell carcinoma.", XP002538810, retrieved from EBI accession no. GSP:ADO55181 Database accession no. ADO55181 *
DATABASE Geneseq [online] 17 January 2001 (2001-01-17), "Human chemokine GROalpha SEQ ID NO: 24.", XP002538811, retrieved from EBI accession no. GSP:AAB15793 Database accession no. AAB15793 *
KHOURSHEED MOUSA ET AL: "Expression of CD44s in human colorectal cancer", PATHOLOGY ONCOLOGY RESEARCH, TUD. KIADO, BUDAPEST, HU, vol. 8, no. 3, 1 September 2002 (2002-09-01), pages 170 - 174, XP008108779, ISSN: 1219-4956 *
MURAI SHINJI ET AL: "Expression and localization of membrane-type-1 matrix metalloproteinase, CD 44, and laminin-5gamma2 chain during colorectal carcinoma tumor progression", VIRCHOWS ARCHIV, SPRINGER INTERNATIONAL, BERLIN, DE, vol. 445, no. 3, 1 September 2004 (2004-09-01), pages 271 - 278, XP008108762, ISSN: 0945-6317 *
OYAMA ATSUSHI ET AL: "CD44 is involved, but VEGF-C and VEGF-D are not, in the lymphatic spread of human colorectal cancer cells implanted orthotopically in nude mice.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, vol. 44, July 2003 (2003-07-01), & 94TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH; WASHINGTON, DC, USA; JULY 11-14, 2003, pages 57, XP001537175, ISSN: 0197-016X *
WEN YU ET AL: "Cellular transformation by GRO alpha involves down-regulation of Fibulin-1.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, vol. 45, March 2004 (2004-03-01), & 95TH ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-FOR-CANCER-RESEARCH; ORLANDO, FL, USA; MARCH 27 -31, 2004, pages 21 - 22, XP001537176, ISSN: 0197-016X *
WIELENGA VERA J M ET AL: "Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression", CANCER RESEARCH, vol. 53, no. 20, 1993, pages 4754 - 4756, XP002538809, ISSN: 0008-5472 *

Also Published As

Publication number Publication date
KR20070058577A (ko) 2007-06-08
WO2006039405A3 (fr) 2007-05-03
EP1794318A2 (fr) 2007-06-13
WO2006039405A2 (fr) 2006-04-13
CA2580528A1 (fr) 2006-04-13
AU2005292025A1 (en) 2006-04-13
US20090112120A1 (en) 2009-04-30
AU2010257379A1 (en) 2011-01-20
JP2008514234A (ja) 2008-05-08
JP2009060908A (ja) 2009-03-26
US20060088862A1 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
EP1794318A4 (fr) Criblage de medicaments et test de diagnostic moleculaire pour un depistage precoce du cancer colorectal, reactifs, procedes et trousses associes
BRPI0607508B8 (pt) método para detecção e/ou classificação de distúrbios proliferativos celulares colorretais ou hepatocelulares, e uso do mesmo
IL180997A0 (en) Diagnostic methods and kits utilizing platelet biomarkers for cancer
PL1687609T3 (pl) Sondy fluoroscencyjne do wykrywania DNA przez hybrydyzację o ulepszonej czułości i niskim tle
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
WO2007141280A3 (fr) protéines
WO2007089911A3 (fr) procedes de detection de cellules tumorales circulantes et procedes de diagnostic de cancer chez un sujet mammalien
WO2005041893A3 (fr) Detection des biomarqueurs de l'infarctus aigu du myocarde
HK1110905A1 (en) Kits and methods for detecting methylated dna
WO2007056523A3 (fr) Procedes de diagnostic et de surveillance de la progression d'un cancer
EP2540842B8 (fr) Procédés et sondes pour détecter un cancer de l'oesophage
WO2009019368A3 (fr) Procede de dosage de la liver fatty acid-binding protein, de l'ace et du ca19-9 pour le diagnostic in vitro du cancer colorectal
IL211255A0 (en) Cop1 molecules and uses thereof
PL1904627T3 (pl) Sposób przygotowania wirusa PRRS i jego białek oraz diagnostycznych zestawów testowych przeznaczonych do jego detekcji
WO2009024691A3 (fr) Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal
EP2118653A4 (fr) Materiaux et methodes pour detecter efficacement et precisement des analytes
WO2010033371A3 (fr) Marqueurs moléculaires pour les carcinomes pulmonaires et colorectaux
IL178472A0 (en) Three time point lung cancer detection, diagnosis and assessment of prognosis
EP2021512A4 (fr) Systèmes et procédés destinés à développer des tests diagnostiques sur la base d'informations de biomarqueurs provenant d'ensembles d'échantillons cliniques existants
EP2048501A4 (fr) Anticorps spécifique dirigé contre l'autotaxine humaine intacte, procédé de criblage dudit anticorps et procédé et réactif destinés à l'examen d'un lymphome malin par une analyse de l'autotaxine
EP2484778A3 (fr) Procédés et acides nucléiques pour la détection de troubles prolifératifs cellulaires colorectaux
WO2008048508A3 (fr) Biomarqueurs pronostiques chez des patientes souffrant d'un cancer des ovaires
AP2316A (en) Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same.
EP1869211A4 (fr) Snp multiple pour diagnostiquer le cancer colorectal, micromatrice et trousse le comprenant, et procédé de diagnostic du cancer colorectal l'utilisant
WO2009019370A3 (fr) Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070302

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

R17D Deferred search report published (corrected)

Effective date: 20070503

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/536 20060101ALI20070626BHEP

Ipc: C12P 19/34 20060101ALI20070626BHEP

Ipc: C07K 1/00 20060101ALI20070626BHEP

Ipc: C07H 21/02 20060101AFI20070626BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1104583

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20090805

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101ALI20090728BHEP

Ipc: G01N 33/536 20060101ALI20090728BHEP

Ipc: C12P 19/34 20060101ALI20090728BHEP

Ipc: C07K 1/00 20060101ALI20090728BHEP

Ipc: C07H 21/02 20060101AFI20070626BHEP

17Q First examination report despatched

Effective date: 20100325

17Q First examination report despatched

Effective date: 20111006

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120331

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1104583

Country of ref document: HK